Search

Introduction. The imbalance of the immune response is an important factor contributing to the incidence of ocular toxoplasmosis (OT). Regulatory T cells (Treg) play a key role in maintaining the balance between Th1 and Th17 immune responses, while interleukin-27 (IL-27) levels are related to the differentiation of Th17 cells. This study analyzes the differences in the number of Treg cells and the level of IL-27 between OT patients and seropositive individuals without ocular lesions and its correlation with retinal lesion size. Methods. This analytic observational study, conducted for 8 months, involved 11 OT patients and 10 seropositive individuals without ocular lesions. All subjects underwent a comprehensive ophthalmological examination. Retinal lesions were documented by fundus photographs and the size was measured using Digimizer 4.2.2.0 software. Isolation of peripheral blood mononuclear cells (PBMC) was performed to measure the number of Treg cells using flow cytometry and interleukin-27 levels were assessed using the Sandwich enzyme-linked immunosorbent assay (ELISA) technique. Data were analyzed with SPSS. Result. The number of Treg cells in the OT group (47.16 ± 15.66%) was lower than in the seropositive group without the ocular lesions (62.86 ± 17.08%) (p = 0.029). The serum IL-27 levels in the OT group were not significantly different from the seropositive group without the ocular lesions (p = 0.360). The number of Treg cells was significantly related to retinal lesion size (p = 0.043), with a correlation coefficient of −0.648, indicating a strong and inverse correlation. There was no significant correlation between serum IL-27 levels and retinal lesion size (p = 0.556). Conclusion. Ocular toxoplasmosis patients have a low number of Treg cells that are inversely related to the retinal lesion size. The size of the retinal lesion increases as the number of Treg cells decreases. [ABSTRACT FROM AUTHOR]

Keloid is connective skin tissue overgrowth resulting from abnormal wound healing activated by transforming growth factor-β (TGF-β) through particularly TGF-β/Smad signaling pathway which translocate Smad2/3 into nucleus to induce type I collagen synthesis and normally regulated by inhibitory Smad7. The expression of Smad2/3 are increased while Smad7 is decreased in keloid fibroblast. The keloid fibroblast phosphorylated p38 (p-p38) increased and inhibited Smad7 expression. Those biomolecular findings cause keloid recurrence. Therefore, studies on keloid recurrence prevention must be developed. Quercetin is a flavonoid found in many fruits and vegetables. Previous studies showed that quercetin inhibited p-p38 which provided opportunity increasing Smad7, decreasing nuclear Smad2/3, and preventing keloid recurrence. This study aimed to determine the quercetin effect on p-p38, Smad7, Smad2/3, and collagen type I levels in human keloid fibroblasts. Four replicates three-passages primary human keloid fibroblast culture incubated with 5, 10, 20 µg/mL quercetin were conducted with culture media as control for 48 hours. The expressions of p-p38, Smad7, and Smad2/3 were measured using western blotting. The level of collagen type I was measured using enzyme-linked immunosorbent assay (ELISA). Mean comparisons between multiple groups were analyzed using one-way analysis of variance (ANOVA) or Kruskal-Wallis test. Mean comparison between two groups were analyzed using independent T-test or Mann-Whitney test. The results showed that 10 µg/mL quercetin group showed lower p-p38 expression than that of control group (P < 0.05). The 10 and 20 µg/mL quercetin groups showed lower Smad7 expression than that of control (P < 0.05). The 20 µg/mL quercetin group showed lower nuclear Smad2/3 expression than that of control (P < 0.05). All quercetin groups demonstrated lower nuclear Smad2/3 compared to cytoplasmic Smad2/3 expression (P < 0.05), while control group did not show nuclear and cytoplasmic Smad2/3 expression significant difference. This study confirmed that quercetin could regulate keloid fibroblast TGF-β/Smad pathway by inhibiting p-p38 and Smad2/3 nuclear translocation and could be used, as biomolecular basis, for keloid prevention in wound healing process. [ABSTRACT FROM AUTHOR]

Lipopolysaccharide (LPS) and lipooligosaccharide (LOS) are inflammatory response inducers triggering downstream inflammatory signals by binding to the TLR4-MD2 complex. LPS/LOS exposure through TLR4 receptor on dendritic cells (DC) causes an increase in interferon (IFN)-β expression via an increase in interferon regulatory factor (IRF)3 expression and a decrease in nuclear factor (NF)-κβ, which result in HIV replication inhibition. This study aimed to compare the binding affinity between Escherichia coli LPS and Neisseria gonorrhoeae LOS toward TLR4-MD2 in silico and the production of NF-κβ, IRF3, and IFN-β from naive-HIV monocyte-derived dendric cells (MDDCs) after LPS and LOS exposure in vitro, to find a deeper understanding of host immune response, disease pathogenesis, and trends of drug development in the future. Molecular docking and dynamics were analyzed using AutoDock Vina and YASARA, respectively. The naive-HIV DC culture was exposed to LPS at 50, 100, and 200 ng/mL, or LOS at concentrations of 2.5, 5, and 10% for 24-h. Levels of NF-κβ, IRF3, and IFN- β were measured by Enzyme-linked Immunosorbent Assay (ELISA). The results showed that LOS demonstrated higher binding affinity to TLR4-MD2 complex than LPS, although the docking between LOS and TLR4-MD2 complex involved fewer amino acids. Inversely, LPS exposure significantly increased IRF3 and IFN-β production (P < 0.01). Production of IFN-β was significantly increased with higher doses of LOS (P < 0.01). Different doses of LPS induced significant differences in NF-κβ and IFN-β levels (P < 0.01 and P < 0.05, respectively). Despite LOS showing higher binding affinity to TLR4- MD2 complex, LPS exposure induced higher production of IRF3 and IFN-β from MDDCs. These findings provided information for deeper apprehension of immune responses and disease pathogenesis during HIV co-infections. [ABSTRACT FROM AUTHOR]

Background: During pregnancy, the balanced dominance of the T helper17 response shifts to a Th2 response that is characterised by the production of IL-10, following the completion of the implantation process. Transforming growth factor-β (TGF-β) expression is associated with the completion of trophoblast invasion and placental growth. This study assessed the effect of malaria infection on the levels of IL-17, IL-10, and TGF-β in the plasma of pregnant mice with malaria. Methods: Seventeen pregnant BALB/C mice were divided into two groups: mice infected with Plasmodium berghei (treatment group) and uninfected mice (control group). The mice were sacrificed on day 18 post-mating. Parasitemia was measured by Giemsa staining. The levels of IL-17, IL-10, and TGF-β were measured by ELISA. Results: Using independent t test, the IL-17 levels in the treatment group were higher than those in the control group (P = 0.040). The IL-10 levels in the treatment group were lower than those in the control group (P = 0.00). There was no significant difference in the TGF-β levels (P = 0.055) between two groups. However, using SEM analysis the degree of parasitemia decreased the plasma TGF-β levels (tcount = 5.148; ≥ ttable= 1.96). SEM analysis showed that a high degree of parasitemia increased the IL-17 levels and decreased the IL-10 and TGF-β levels. Conclusion: Malaria infection during pregnancy interferes with the systemic balance by increasing the IL-17 levels and decreasing the IL-10 and TGF-β levels. [ABSTRACT FROM AUTHOR]